1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AC006486.9 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA AC007192.4 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA AC007906.1 CTRPv2 pan-cancer AAC 0.092 0.008
mRNA AC008074.1 CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA AC009065.1 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA AC009133.23 CTRPv2 pan-cancer AAC 0.11 0.0008
mRNA AC011155.1 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA AC011530.4 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA AC013264.1 CTRPv2 pan-cancer AAC 0.16 0.0001
mRNA AC015688.3 CTRPv2 pan-cancer AAC -0.13 0.0003
Download CSV